MARKET

SRPT

SRPT

Sarepta
NASDAQ

Real-time Quotes | Nasdaq Last Sale

109.46
-0.50
-0.45%
After Hours: 109.46 0 0.00% 17:11 12/06 EST
OPEN
110.52
PREV CLOSE
109.96
HIGH
110.77
LOW
108.72
VOLUME
573.47K
TURNOVER
--
52 WEEK HIGH
158.80
52 WEEK LOW
72.05
MARKET CAP
8.16B
P/E (TTM)
-12.7851
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SRPT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SRPT News

  • Why Is Sarepta Therapeutics (SRPT) Up 17.2% Since Last Earnings Report?
  • Zacks.1d ago
  • The Zacks Analyst Blog Highlights: uniQure, Sarepta Therapeutics, BioMarin Pharmaceutical and Sangamo Therapeutics
  • Zacks.2d ago
  • Astellas-Audentes Deal Likely to Ignite More Acquisitions
  • GuruFocus.com.3d ago
  • 4 Solid Gene Therapy Buyout Bets Post Audentes-Astellas Deal
  • Zacks.3d ago

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About SRPT

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its product, EXONDYS 51, indicated for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. EXONDYS 51 is studied in clinical trials under the name of eteplirsen. Its next generation phosphorodiamidate morpholino oligomer (PMO)-based compounds are synthetic compounds that bind to complementary sequences of RNA by standard Watson-Crick nucleobase pairing. Its PMO-based chemistries are peptide conjugated PMO (PPMO), PMO-X and PMOplus.
More

Webull offers Sarepta Therapeutics Inc (SRPT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.